First licensed preparation (Sativex) for muscle spasms is also expensive There is no strong evidence to back the use of cannabis extract in the treatment of Multiple Sclerosis (MS), concludes a review of the available evidence on the first licensed preparation, published in the December issue of Drug and Therapeutics Bulletin (DTB). Sativex, in the form of a mouth spray, contains the principal extracts - dronabinol and cannabidiol - found in the leaf and flower of the cannabis plant. It is the first cannabinoid preparation to be licensed for use in the treatment of muscle spasms in MS...
More...
More...